Frequently bought together

Brand : GLIPTAMET

GLIPTAMET 50/1000/MG FC TAB 56/FC TAB

106.4

Sku : I-013580
Key features
GLIPTAMET 50/1000 mg film-coated tablets contain sitagliptin phosphate 50 mg and metformin hydrochloride 1000 mg as active ingredients. Metformin lowers hepatic glucose production, reduces intestinal glucose absorption and improves insulin sensitivity, while sitagliptin inhibits DPP‑4 to increase endogenous incretins (GLP‑1 and GIP), enhancing glucose‑dependent insulin secretion and suppressing glucagon. It is used to improve glycemic control in adults with type 2 diabetes mellitus. Available as film-coated tablets in packs of 56; prescription only.
- Brand: GLIPTAMET
- Active Ingredient: METFORMIN HYDROCHLORIDE 1000mg, SITAGLIPTIN PHOSPHATE 50mg
- Strength: 1000,50mg
- Dosage Form: Film-coated tablet
- Pack Size: 56 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Antidiabetic
- Pharmacological Group: Oral Antidiabetics
- Manufacturer: PATHEON INC
- Country of Origin: Puerto Rico
- SFDA Registration No.: 2307257840
- Shelf Life: 24 months
- Storage: do not store above 30°c
- Diabetes Type: Type 2

Frequently bought together

Description

Specification

Pharmacology

Mechanism of Action

Metformin decreases hepatic glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity; sitagliptin inhibits DPP-4, increasing endogenous incretins (GLP-1/GIP) to enhance glucose-dependent insulin secretion and suppress glucagon.